GACM
BIIB icon

Green Arrow Capital Management’s Biogen BIIB Stock Holding History

Green Arrow Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,100
Closed -$2.55M – 179
2014
Q2 		$2.55M Sell
8,100
-16,900
-68% -$5.09M 0.32% 90
2014
Q1 		$7.65M Buy
25,000
+16,907
+209% +$5.37M 0.65% 47
2013
Q4 		$2.26M Buy
+8,093
New +$2.09M 0.16% 165
2013
Q3 		– Sell
-15,000
Closed -$3.23M – 258
2013
Q2 		$3.23M Buy
+15,000
New +$3.21M 0.26% 121

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Green Arrow Capital Management's BIIB Position: Q3 2014 in Review

Green Arrow Capital Management sold out of Biogen (BIIB) in Q3 2014, closing a stake of 8,100 shares — an estimated $2.55M sold.

Green Arrow Capital Management first reported a position in BIIB in Q2 2013 and held it in 4 quarters. The position peaked at $7.65M in Q1 2014. 819 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

  • Green Arrow Capital Management reported no remaining Biogen position as of Q3 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 8,100 Biogen shares in Q3 2014, an estimated $2.55M.
  • Green Arrow Capital Management first reported a position in Biogen in Q2 2013 and held it in 4 quarters.
  • Green Arrow Capital Management's Biogen position peaked at $7.65M in Q1 2014.
  • 819 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on Green Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.